Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabor E Linthorst

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Molecular Genetics and Metabolism|December 3, 2010
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)Gabor E Linthorst, Dominique P Germain, Carla E M Hollak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2005
Home treatment for Fabry disease: practice guidelines based on 3 years experience in The NetherlandsGabor E Linthorst, Anouk C Vedder, Els E Ormel, et al.
American Journal of Human Genetics|December 10, 2002
Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNADaniël Blom, Dave Speijer, Gabor E Linthorst, et al.
Kidney International|October 2, 2004
Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and betaGabor E Linthorst, Carla E M Hollak, Wilma E Donker-Koopman, et al.
Journal of Inherited Metabolic Disease|November 15, 2014
Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapyEefje B Suntjens, Bouwien E Smid, Marieke Biegstraaten, et al.
Molecular Genetics and Metabolism|August 2, 2011
Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of lifeMachtelt G Bouwman, Heleen Maurice-Stam, Gabor E Linthorst, et al.
Journal of Inherited Metabolic Disease|March 21, 2012
Prevalence of symptoms in female Fabry disease patients: a case-control surveyMachtelt G Bouwman, Saskia M Rombach, Erica Schenk, et al.
American Journal of Human Genetics|May 22, 2004
Long-term safety and efficacy of enzyme replacement therapy for Fabry diseaseWilliam R Wilcox, Maryam Banikazemi, Nathalie Guffon, et al.
Orphanet Journal of Rare Diseases|March 28, 2013
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brainSaskia M Rombach, Bouwien E Smid, Machtelt G Bouwman, et al.
Kidney International|December 22, 2016
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceRaphael Schiffmann, Derralynn A Hughes, Gabor E Linthorst, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Molecular Genetics and Metabolism|December 3, 2010
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)Gabor E Linthorst, Dominique P Germain, Carla E M Hollak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2005
Home treatment for Fabry disease: practice guidelines based on 3 years experience in The NetherlandsGabor E Linthorst, Anouk C Vedder, Els E Ormel, et al.
American Journal of Human Genetics|December 10, 2002
Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNADaniël Blom, Dave Speijer, Gabor E Linthorst, et al.
Kidney International|October 2, 2004
Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and betaGabor E Linthorst, Carla E M Hollak, Wilma E Donker-Koopman, et al.
Journal of Inherited Metabolic Disease|November 15, 2014
Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapyEefje B Suntjens, Bouwien E Smid, Marieke Biegstraaten, et al.
Molecular Genetics and Metabolism|August 2, 2011
Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of lifeMachtelt G Bouwman, Heleen Maurice-Stam, Gabor E Linthorst, et al.
Journal of Inherited Metabolic Disease|March 21, 2012
Prevalence of symptoms in female Fabry disease patients: a case-control surveyMachtelt G Bouwman, Saskia M Rombach, Erica Schenk, et al.
American Journal of Human Genetics|May 22, 2004
Long-term safety and efficacy of enzyme replacement therapy for Fabry diseaseWilliam R Wilcox, Maryam Banikazemi, Nathalie Guffon, et al.
Orphanet Journal of Rare Diseases|March 28, 2013
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brainSaskia M Rombach, Bouwien E Smid, Machtelt G Bouwman, et al.
Kidney International|December 22, 2016
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceRaphael Schiffmann, Derralynn A Hughes, Gabor E Linthorst, et al.
Pageof 7